It acts simultaneously on glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors a mechanism that distinguishes it from currently approved therapies such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro)
Current protocols in regenerative aesthetics highlight their role in maintaining skin health without aggressive exfoliation, aligning closely with the broader understanding of what are copper peptides
use alternative contraceptive methods during treatment initiation and for 4 weeks after each dose escalation Concomitant medications: Avoid coadministration with other GLP-1 receptor agonists for weight management Patients should be advised to seek medical attention for: Severe, persistent abdominal pain that may radiate to the back (potential pancreatitis) Signs of thyroid tumors including neck mass, dysphagia, dyspnea, or persistent hoarseness Symptoms of acute gallbladder disease (right upper quadrant pain, fever, jaundice) Severe gastrointestinal symptoms leading to dehydration Changes in vision or signs of hypoglycemia Signs of hypersensitivity reactions including rash, itching, or difficulty breathing Clinicians should conduct a thorough medical history before initiating tirzepatide, including assessment for personal or family history of medullary thyroid carcinoma or MEN 2, history of pancreatitis, severe gastrointestinal disease, and diabetic retinopathy
a majority of the publications are from case reports or case-series, and there is a lack of long-term follow up (82,117)
Due to its molecular structure, however, it is sensitive to enzymatic degradation conventional glutathione therefore often fails to fully reach the target structures in the body
